An ambitious plan to reduce heart diseases in the GCC by up to 25 per cent within the next 15 years and encourage scientific research was yesterday approved.
Twelve recommendations were endorsed on the last day of the 11th Gulf He
There have been a large number of premature deaths in the Middle East region and governments need to urgently prevent lifestyle diseases in the population, said report citing a senior World Health Organisation (WHO) official.
An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major late-stage clinical study, dealing a blow to one of the company's biggest new treatment hopes.
Exercise may be just as good as medication to treat heart disease and should be included as a comparison when new drugs are being developed and tested, scientists said on Wednesday.
In a large review published in the British Medic
Bahrain City Centre (BCC), the largest shopping mall in the Kingdom, is taking part in a global awareness campaign on the prevention of heart diseases amongst women.
Go Red for Women will be held within the mall premises on May 23
Americans at high risk for heart problems who have been told for years to sharply cut salt from their diet may not actually benefit from ultra-low sodium diets and could even face some harm, an independent panel of health experts said.
Common visible signs of aging may not just be a vanity or employment problem, it may also be a harbinger of heart disease, Danish researchers have found.
In a large, long-term study, people who displayed three to four signs of agi
Taking a daily multivitamin does not reduce the risk of heart disease for older men, according to data from a large study presented on Monday.
About half of US adults take at least one daily dietary supplement, the most popular be
Majid Al Futtaim Properties, a leading developer of malls and hotels in the region, has partnered with Dubai Health Authority and Emirates Cardiac Society to launch a major awareness drive on the killer cardiovascular disease (CVD).
Swiss drugmaker Roche has ended efforts to develop a heart disease drug that according to some industry analysts could have achieved $10 billion annual sales, after poor results from a late stage trial.